Global Mycoses Market to Receive Overwhelming Hike in Revenues by 2014 – 2020

Mycoses are fungal skin infections caused by fungi and are primarily caused by three groups of fungi: dermatophytes, yeasts and molds. Dermatophytes cause fungal infections on head and feet, for instance, trichophyton and microsporum. Yeasts cause infections at the genital area, mouth area and esophagus. Example of yeast fungi includes candida and pityrosporum. Molds are responsible for infection in internal organs that results in systemic mycoses, for example, aspergillus. Systemic mycoses lead to the spread of fungi via bloodstream to other organs, causing multiple organ failure.

Report Overview and TOC: https://www.transparencymarketresearch.com/mycoses-market.html

Mycoses are caused due to weakened immune systems, i.e., immunocompromised state that includes patients with HIV/AIDS and patients being treated with corticosteroids for a prolonged period. Other causes include poorly controlled diabetes, being overweight, and any sort of contact with contaminated items such as clothes, towel, etc. Tests used to diagnose mycoses include a general physical examination of the body, complete blood count, skin biopsy, flow cytometry and immunophenotyping.

Request brochure: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=3112

Based on treatment, the mycoses market can be segmented as follows:

Photodynamic therapy: The therapy uses laser light and a drug to destroy the fungal cancer cells

Radiation therapy: The therapy uses high-energy X-rays or radiation to prevent the fungal cells from spreading

Chemotherapy: Chemotherapy stops the growth of fungal cells with the aid of various drugs, either by preventing the cells from dividing or by killing the cells

Targeted therapy: The therapy identifies the affected cells without harming normal cells

Drug medication: Antifungal medications such as amphotericin B, fluconazole, caspofungin, and itraconazole are used for the treatment of mycoses

Based on geography, the mycoses market can be segmented into four major regions: North America, Europe, Asia Pacific and Rest of the World (RoW). Out of these regions, North America holds a leading position in the mycoses market followed by Europe. According to National Institutes of Health, mycoses affect approximately 200,000 people in the U.S. every year. The major factors which are driving the growth of the market in these regions are increasing prevalence of AIDS/HIV across the North American region, leading to weakened immune systems of individuals and constantly growing awareness about mycoses. Asia Pacific is also expected to be one of the promising markets for the growth of mycoses market due to faster developing rate of Asia Pacific countries.

For Specific and Customized requirements@ https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=3112

The advantageous factors which would accelerate the growth of the market in Asia Pacific are presence of large population base in countries such as China, Japan, and India, prevalence of numerous diabetes patients and, population’s changing lifestyle and environmental conditions. Furthermore, various tax benefits and favorable reimbursement policies in developing nations are most likely to augment the growth of mycoses market.

Various pharmaceutical companies are coming up with novel therapeutic treatments for mycoses. Some of the top players operating in mycoses market for mycoses therapeutic development are Bayer AG, Dr. Reddy’s Laboratories Limited, Helix BioMedix, Inc., Merck & Co., Inc., Pfizer, Inc., Nuvo Research, Inc., Moberg Derma AB, Novabiotics Ltd, Pacgen Biopharmaceuticals Corporation, Quinnova Pharmaceuticals, Inc., Xel Pharmaceuticals, Inc. and others.

Pre Book full report@ https://www.transparencymarketresearch.com/checkout.php?rep_id=3112<ype=S

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact us:

Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com

This release was published on openPR.